Mark Pegram, MD, Stanford Women's Cancer Center

Articles by Mark Pegram, MD, Stanford Women's Cancer Center

Dr. Pegram on the Evolving Treatment Landscape in HER2+ Breast Cancer

ByMark Pegram, MD, Stanford Women's Cancer Center

July 29th 2022

Mark Pegram, MD, discusses the evolving treatment landscape of HER2-positive breast cancer.

Monitoring Patients for Interstitial Lung Disease

ByJoyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center,Mark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute

October 1st 2021

Experts discuss the optimal monitoring of patients to identify interstitial lung disease early and how to intervene.

Identifying Risk Factors for Interstitial Lung Disease

ByJoyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center,Mark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute

October 1st 2021

A brief review of the full spectrum of risk factors that impact the likelihood of interstitial lung disease.

Identifying ILD: Symptomology and Work-Up

ByJoyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Mark Pegram, MD, Stanford Women's Cancer Center

September 24th 2021

Comprehensive insight on the symptomology of interstitial lung disease, followed by tools and methods that can aid in accurate diagnosis.

An Overview of Interstitial Lung Disease

ByJoyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center,Mark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute

September 24th 2021

Joyce A. O’Shaughnessy, MD, provides an overview of interstitial lung disease, considering both causes and possible risk factors.

Multidisciplinary Care in Breast Cancer: Take-Home Messages

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 22nd 2021

Take-home messages regarding the optimal identification and management of ILD in breast cancer through the lens of multidisciplinary care.

Practical Considerations for Identifying and Managing ILD in Breast Cancer

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 22nd 2021

Drawing from personal experience, experts provide practical advice on identifying and treating interstitial lung disease in patients with breast cancer during the era of COVID-19.

Optimal Management of ILD in Patients With Breast Cancer

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 15th 2021

Shared insight on the optimal management of patients who develop interstitial lung disease while receiving therapy for breast cancer.

Breast Cancer Management: Monitoring Patients for ILD

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 15th 2021

In light of breast cancer therapies with the potential to cause interstitial lung disease, experts consider important patient risk factors and best monitoring practices.

Multidisciplinary Care for a Patient With Metastatic HER2+ Breast Cancer

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 8th 2021

An overview of optimal multidisciplinary care for a patient who presents with HER2+ metastatic breast cancer.

Challenges in the Multidisciplinary Management of Breast Cancer

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 8th 2021

Key opinion leaders highlight the challenges inherent in using multidisciplinary care to manage breast cancer, particularly when a patient is seen at multiple institutions.

Multidisciplinary Care in BC: How Best to Communicate Patient Information

ByMark Pegram, MD, Stanford Women's Cancer Center,Charles A. Powell, MD, MBA, Mount Sinai-National Jewish Health Respiratory Institute,Joyce O'Shaughnessy, MD, Baylor-Sammons Cancer Center

September 1st 2021

Focusing on the value of electronic systems and tumor boards, experts detail how best to communicate across disciplines in the management of breast cancer.